Leflunomide/hydroxychloroquine combination therapy targets type I IFN-associated proteins in patients with Sjögren's syndrome that show potential to predict and monitor clinical response
来氟米特/羟氯喹联合疗法靶向干燥综合征患者体内I型干扰素相关蛋白,有望用于预测和监测临床疗效
期刊:RMD Open
影响因子:4.7
doi:10.1136/rmdopen-2023-002979
Hamkour, Safae; van der Heijden, Eefje Hm; Lopes, Ana P; Blokland, Sofie L M; Bekker, Cornelis P J; Van Helden-Meeuwsen, Cornelia G; Versnel, Marjan A; Kruize, Aike A; Radstake, Timothy Rdj; Leavis, Helen L; Hillen, Maarten R; van Roon, Joel Ag